这是一篇来自已证抗体库的有关人类 HNRNPH1的综述,是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合HNRNPH1 抗体。
HNRNPH1 同义词: HNRPH; HNRPH1; hnRNPH

艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s5a
艾博抗(上海)贸易有限公司 HNRNPH1抗体(abcam, ab10374)被用于被用于免疫印迹在人类样本上 (图 s5a). Oncogenesis (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 HNRNPH1抗体(Abcam, ab10374)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Oncogene (2021) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 非洲爪蛙; 1:500; 图 4g
艾博抗(上海)贸易有限公司 HNRNPH1抗体(Abcam, ab154894)被用于被用于免疫细胞化学在非洲爪蛙样本上浓度为1:500 (图 4g). elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:10,000; 图 1i
艾博抗(上海)贸易有限公司 HNRNPH1抗体(Abcam, ab10374)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 1i). Nat Neurosci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5g
艾博抗(上海)贸易有限公司 HNRNPH1抗体(Abcam, ab10374)被用于被用于免疫印迹在人类样本上 (图 5g). J Biol Chem (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:5000; 图 1
艾博抗(上海)贸易有限公司 HNRNPH1抗体(Abcam, 10374)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1). PLoS Genet (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(1G11)
  • 免疫印迹; 人类; 图 4e
圣克鲁斯生物技术 HNRNPH1抗体(Santa Cruz Biotechnology, sc-32310)被用于被用于免疫印迹在人类样本上 (图 4e). Proc Natl Acad Sci U S A (2018) ncbi
小鼠 单克隆(1G11)
  • 免疫印迹; 人类; 图 s5a
圣克鲁斯生物技术 HNRNPH1抗体(Santa Cruz, sc-32310)被用于被用于免疫印迹在人类样本上 (图 s5a). Cancer Cell (2017) ncbi
小鼠 单克隆(1G11)
  • 免疫细胞化学; 人类; 1:1000; 图 4c
  • 免疫印迹; 人类; 1:1000; 图 2c
圣克鲁斯生物技术 HNRNPH1抗体(Santa Cruz Biotechnology, sc-32310)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 4c) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nucleic Acids Res (2017) ncbi
小鼠 单克隆(1G11)
  • 免疫印迹; 人类
圣克鲁斯生物技术 HNRNPH1抗体(Santa Cruz Biotech, 1G11)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
文章列表
  1. Ashok C, Ahuja N, Natua S, Mishra J, Samaiya A, Shukla S. E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression. Oncogenesis. 2021;10:58 pubmed 出版商
  2. Wu Y, Guo Q, Ju X, Hu Z, Xia L, Deng Y, et al. HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene. 2021;40:4770-4782 pubmed 出版商
  3. Koppers M, Cagnetta R, Shigeoka T, Wunderlich L, Vallejo Ramirez P, Qiaojin Lin J, et al. Receptor-specific interactome as a hub for rapid cue-induced selective translation in axons. elife. 2019;8: pubmed 出版商
  4. Laferrière F, Maniecka Z, Pérez Berlanga M, Hruska Plochan M, Gilhespy L, Hock E, et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci. 2019;22:65-77 pubmed 出版商
  5. Fan L, Zhang F, Xu S, Cui X, Hussain A, Fazli L, et al. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells. Proc Natl Acad Sci U S A. 2018;115:E4584-E4593 pubmed 出版商
  6. Marchesini M, Ogoti Y, Fiorini E, Aktaş Samur A, Nezi L, D Anca M, et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell. 2017;32:88-100.e6 pubmed 出版商
  7. Aviner R, Hofmann S, Elman T, Shenoy A, Geiger T, Elkon R, et al. Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis. Nucleic Acids Res. 2017;45:5945-5957 pubmed 出版商
  8. Li W, Li H, Zhang L, Hu M, Li F, Deng J, et al. Long non-coding RNA LINC00672 contributes to p53 protein-mediated gene suppression and promotes endometrial cancer chemosensitivity. J Biol Chem. 2017;292:5801-5813 pubmed 出版商
  9. Bondy Chorney E, Crawford Parks T, Ravel Chapuis A, Klinck R, Rocheleau L, Pelchat M, et al. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier. PLoS Genet. 2016;12:e1005827 pubmed 出版商
  10. Koumbadinga G, Mahmood N, Lei L, Kan Y, Cao W, Lobo V, et al. Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor. Biochim Biophys Acta. 2015;1849:1095-103 pubmed 出版商